Modification of the Coomassie brilliant blue staining method for sphingolipids and sphingolipid synthesis inhibitors on silica gel thin-layer plate.
Abe
A
A
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109-0676, USA.
D000818:Animals; D002460:Cell Line; D002855:Chromatography, Thin Layer / Q000379:methods*; D004285:Dogs; D004791:Enzyme Inhibitors / Q000032:analysis / Q000494:pharmacology; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors; D009025:Morpholines / Q000032:analysis / Q000494:pharmacology; D012394:Rosaniline Dyes; D058428:Silica Gel; D012822:Silicon Dioxide; D013107:Sphingolipids / Q000032:analysis* / Q000096:biosynthesis; D013194:Staining and Labeling / Q000379:methods*
D004791:Enzyme Inhibitors; D009025:Morpholines; D012394:Rosaniline Dyes; D013107:Sphingolipids; D058428:Silica Gel; C033110:RV 538; D012822:Silicon Dioxide; D005964:Glucosyltransferases; C023246:ceramide glucosyltransferase; C004692:coomassie Brilliant Blue